The effect of FII c.1787G>A (prothrombin Belgrade) mutation on prothrombin gene expression in vitro


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The FII c.1787G>A (prothrombin Belgrade) is a novel prothrombotic mutation which leads to impaired inhibition of thrombin by antithrombin (antithrombin resistance). So far, the mechanism of this variant has not been fully elucidated. To investigate the effect of FII c.1787G>A mutation on the prothrombin gene expression, its functional analysis was performed in vitro. By Real-Time PCR, expression levels of FII gene variants were evaluated in Cos-7 cells transiently transfected with c.1787G (wild-type) and c.1787A prothrombin expression vectors, with no differences observed. The relative quantification of prothrombin protein amounts was accomplished by Western blot analysis, also with no differences observed. Therefore, the mechanism of FII c.1787G>A mutation does not alter prothrombin expression profile.

About the authors

M. Gvozdenov

Institute of Molecular Genetics and Genetic Engineering

Author for correspondence.
Email: majagvozdenov@yahoo.com
Serbia, Belgrade

I. Pruner

Institute of Molecular Genetics and Genetic Engineering

Email: majagvozdenov@yahoo.com
Serbia, Belgrade

B. Tomic

Institute of Molecular Genetics and Genetic Engineering

Email: majagvozdenov@yahoo.com
Serbia, Belgrade

M. Kovac

Faculty of Medicine; Blood Transfusion Institute of Serbia

Email: majagvozdenov@yahoo.com
Serbia, Belgrade; Belgrade

D. Radojkovic

Institute of Molecular Genetics and Genetic Engineering

Email: majagvozdenov@yahoo.com
Serbia, Belgrade

V. Djordjevic

Institute of Molecular Genetics and Genetic Engineering

Email: majagvozdenov@yahoo.com
Serbia, Belgrade

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Inc.